Correspondence: David Reiter, MD, DMD, MBA, Department of Otolaryngology–@Head & Neck Surgery, Jefferson Medical College, 925 Chestnut St, Sixth Floor, Philadelphia, PA 19107 (email@example.com).
Objectives To determine current practice for use of perioperative antibiotics among facial plastic surgeons, to determine the extent of use of literature support for preferences of facial plastic surgeons, and to compare patterns of use with nationally supported evidence-based guidelines.
Methods A link to a Web site containing a questionnaire on perioperative antibiotic use was e-mailed to more than 1000 facial plastic surgeons in the United States. Responses were archived in a dedicated database and analyzed to determine patterns of use and methods of documenting that use. Current literature was used to develop evidence-based recommendations for perioperative antibiotic use, emphasizing current nationally supported guidelines.
Results Preferences varied significantly for medication used, dosage and regimen, time of first dose relative to incision time, setting in which medication was administered, and procedures for which perioperative antibiotic was deemed necessary.
Conclusions Surgical site infection in facial plastic surgery can be reduced by better conformance to currently available evidence-based guidelines. We offer specific recommendations that are supported by the current literature.
Despite the growing focus of payers and regulatory agencies on evidence-based use of perioperative antibiotics to reduce surgical site infections, the administration of antibiotic prophylaxis in facial plastic and reconstructive surgery remains erratic and highly controversial. There are virtually no published outcomes studies on the effectiveness of antibiotic prophylaxis in nontraumatic facial plastic and reconstructive surgery and even fewer published reports based on controlled clinical trials. Published surveys of plastic and facial plastic surgeons suggest frequent use of perioperative antibiotics without consistency or adherence to evidence-based guidelines.
A link to a Web site containing a questionnaire on perioperative antibiotic use was included in the weekly e-mail bulletin sent out by the American Academy of Facial Plastic and Reconstructive Surgery to approximately 1700 members, fellows, and office contacts during the third week of December 2004. One hundred fourteen complete, distinct responses were received, as confirmed by logging the Internet Protocol addresses of the respondents. The survey (Figure 1) included questions regarding whether the surgeon had a routine for administration of perioperative antibiotics, when the antibiotics were given, who gave the antibiotic, how the administration was documented, and the duration of administration following surgery. The responses were archived in a dedicated database and analyzed to determine patterns of use and methods of documenting that use.
Facial plastic surgery perioperative anitbiotic usage survey.
The majority of facial plastic surgeons responding to our survey use antibiotic prophylaxis. Antibiotic choice and details regarding administration of the antibiotic vary widely.
Ninety-one percent (n = 104) of those surveyed use antibiotic prophylaxis routinely. However, only 34% (39) use prophylaxis for all cases. Thirty-seven percent (n = 42) decide to use prophylaxis on a case-by-case basis, with 16% using antibiotics for long or contaminated cases, 10% (11) using antibiotics only for contaminated cases, and 4% (4) usingantibiotics only for long cases. Forty-nine percent (n = 43) replied that they used antibiotics postoperatively for more than 24 hours. Forty-three percent (n = 39) give 1 dose, and 11% (n = 12) continue the regimen for 24 hours after surgery (Figure 2).
Duration of antibiotic treatment.
A first-generation cephalosporin is the overwhelming antibiotic of choice, picked by 91% of respondents (n = 104). A smaller number used a second- or third-generation cephalosporin or amoxicillin–clavulanate potassium (Augmentin; GlaxoSmithKline, Uxbridge, England) (Figure 3). Interestingly, no surgeon chose penicillin, vancomycin, gentamycin, or azithromycin, which were also possible choices.
Perioperative antibiotic choice.
Most surgeons (81 [71%] of 114) administer antibiotics using a written order at admission, whereas 18% (n = 20) administer antibiotics at admission with a verbal order. A small number of surgeons (9%) provide a formal order written prior to admission (Figure 3). A nurse or a member of the anesthesiology staff usually gives and documents the physical administration of the antibiotic (Figure 4). One respondent indicated that no one documents the administration.
Surgical staff member who (A) documents antibiotic administration and (B) administers the antibiotic.
An extensive literature review was performed; to our knowledge, no such study has been conducted before in facial plastic surgery or otolaryngology. A few surveys1-3 were performed by general plastic surgeons, and our findings are similar to those.
The plastic surgery literature suggests that most general plastic surgeons use perioperative antibiotics for facial plastic surgical procedures, although there are few supporting studies with outcome data. Most recently, Perrotti et al. 1 sent a survey to members of the American Society of Plastic and Reconstructive Surgeons. Over 90% of the more than 1000 responding surgeons indicated that they routinely use antibiotics for face-lift, rhinoplasty, or blepharoplasty. An additional study by Krizek et al.2 included responses from more than 1000 plastic surgeons in the United States and Canada. This survey revealed that 50% of surgeons performing rhinoplasty with implants used perioperative antibiotics. Krizek et al.2 went on to perform a second survey,3 where they found again that most plastic surgeons use perioperative antibiotics.
Similar to our study, Perotti et al.1 found that cephalosporins were the most commonly used antibiotic. There is no controversy over this choice. The efficacy of high-dose, first-generation cephalosporins, primarily cefazolin, as prophylaxis in clean, contaminated head and neck surgery is well documented.4 An early landmark study5 performed in 1979 comparing cefazolin to placebo in patients undergoing head and neck cancer surgery was terminated prior to complete accrual because of the extensive improvement in surgical site infection rates in patients receiving antibiotic.
We found no published study of methods for ordering, administering, and documenting perioperative antibiotic use. However, Krizek et al.2 commented that 63% of plastic surgeons administer antibacterial agents prior to surgery—14.1% during surgery and 22.9% after surgery.
The American Academy of Otolaryngology–Head & Neck Surgery has proposed specific basic principles for prophylaxis against surgical site infection. First, antimicrobials must be present at therapeutic levels at the time of incision. Antibiotics should be administered 1 hour preoperatively if given orally and shortly before anesthetic induction if given intravenously. In addition, antibiotic administered after 24 hours is not considered protective.6
Facial plastic surgery encompasses a wide variety of procedures, most of which are classified as clean or clean, contaminated surgery by the classification system of the National Academy of Sciences, National Research Council.7 Examples of clean surgery include blepharoplasty and face-lift. The infection rate for clean wounds is generally reported to be less than 2% in nonsmokers. Although some controversy exists in the literature regarding the use of antibiotics for clean surgery (placing incisions in surgically prepared skin), the 2003 guidelines set forth by the American Academy of Otolaryngology–Head & Neck Surgery state that antimicrobial prophylaxis is generally unnecessary for clean-only incisions in healthy patients.6
Krizek et al.2 point out that a very large series would be needed to show any benefit from the use of prophylactic antibiotics in such procedures, as the surgical site infection rate is so low and the expected difference in outcomes between the control and study samples so small. One relatively large study performed by Baran et al.8 in 1999 classified 1400 patients into 4 groups, including 1 group of 300 patients who underwent a cosmetic surgical procedure (rhinoplasty, blepharoplasty, rhytidectomy, abdominoplasty, liposuction, or reduction mammoplasty). These patients were randomized to receive a therapeutic intravenous single dose of ampicillin-sulbactam or placebo. There was no statistically significant difference in the infection rate between the group receiving antibiotic and the group receiving placebo. Furthermore, Johnson and Wagner9 retrospectively reviewed the records of 438 patients who had undergone uncontaminated head and neck surgery. Only 3 patients (1%) developed infection, one of whom had received antibiotic prophylaxis. They therefore concluded that perioperative antibiotic offered only “nonefficacy” for inpatients undergoing clean head and neck surgery.
There has been much attention and debate in the literature surrounding the use of antibiotics for clean nasal surgery, primarily rhinoplasty or septoplasty. No placebo-controlled studies were found for this type of surgery, and there is no statistical evidence in the otolaryngology or plastic surgery literature to support the use of perioperative antibiotic use for clean nasal surgery. It should be noted, however, that local infection and severe complications such as toxic shock syndrome have been rarely reported.10 Yoder and Weimert11 evaluated 1040 patients undergoing septal surgery and found that infections developed in only 0.5% of patients. They conclude that perioperative antibiotics are not warranted in septal surgery. Furthermore, Slavin et al.12 prospectively evaluated preoperative and intraoperative blood cultures of 52 healthy patients admitted for rhinoplasty. Only 1 culture grew a microorganism (which the authors attribute to contamination), and no local or systemic infections were noted in any patients throughout a 60-day postoperative period. Slavin et al12 concluded that “the value of perioperative antibiotic prophylaxis is questionable [in rhinoplasty].” Silk et al.13 also concluded that staphylococcal bacteremia during nasal septoplasty is a rare occurrence and that antimicrobial prophylaxis is unnecessary.
Regarding length of perioperative antibiotic use, the survey by Perrotti et al.1 reveals that 25% of respondents prescribe antibiotics for longer than 4 days after face-lift; 31%, after rhinoplasty; and 15%, after blepharoplasty.1 Almost half of our respondents prescribe antibiotics for longer than 24 hours. These findings are in contrast to the current recommendation to discontinue perioperative antibiotics at 24 hours postsurgery. Even in contaminated head and neck surgery, where perioperative antibiotics have proved to be advantageous, no benefit is seen by administration of antibiotics for longer than 24 hours postoperatively.4
Adherence to hospital guidelines and documentation of administration are topics of concern in many institutions in the United States and internationally. Inappropriate antibiotic prophylaxis contributes to the emergence of resistant organisms as well as increased cost and risk to patients. Our survey reveals that there is no agreement among those surveyed concerning orders for and documentation of antibiotic administration. A French study14 analyzed the use of antibiotic prophylaxis in the wake of 2 French consensus conferences attempting to evaluate and improve adherence to guidelines. The study involved the administration to anesthesiologists of 2 surveys regarding indications, choice of drugs, dosage, timing, and treatment duration. The first survey included all patients admitted for a surgical procedure during a 15-day period. Sixty-nine percent of antibiotic administration was found to be inappropriate. Local recommendations were subsequently distributed to all anesthesiologists, anesthetists, and surgeons in the hospital. In addition, the recommendations were displayed in the operating rooms. A second, similar survey (taken 3 months later) revealed that only 18% of antibiotic administration was inappropriate. The authors conclude that successful intervention depends on a hospital-wide education program.
In conclusion, despite the absence of distinct guidelines and evidence-based literature to support its use, perioperative antibiotic administration seems to be common in facial plastic surgery as well as general plastic surgery. In addition, despite increasing interest in regulation and standardization of perioperative antibiotic administration, the documentation and use of prophylaxis varies widely among surgeons. Certainly, large-scale studies are greatly needed in this area to determine correct and appropriate use of antibiotics to avoid unnecessary risk and cost to patients, payers, and hospitals. Hospital-wide education and awareness has proved useful outside the United States. We propose that such education and guidelines in the context of evidence-based decision making become standard for facial plastic surgeons.
Correspondence: David Reiter, MD, DMD, MBA, Department of Otolaryngology–Head & Neck Surgery, Jefferson Medical College, 925 Chestnut St, Sixth Floor, Philadelphia, PA 19107 (firstname.lastname@example.org).
Accepted for Publication: May 25, 2005.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Facial Plastic Surgery editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 4
Customize your page view by dragging & repositioning the boxes below.
Users' Guides to the Medical Literature
Users' Guides to the Medical Literature
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.